Assessment of Congenital Cytomegalovirus Prevalence among Newborns in Minnesota during the COVID-19 Pandemic

Mark R. Schleiss, Sondra Rosendahl, Mark McCann, Sheila C. Dollard, Tatiana M. Lanzieri

Research output: Contribution to journalLetterpeer-review

4 Scopus citations

Abstract

This cross-sectional study assesses the prevalence of congenital cytomegalovirus infection among newborns screened in Minnesota before and during the COVID-19 pandemic.

Original languageEnglish (US)
Pages (from-to)E2230020
JournalJAMA Network Open
Volume5
Issue number9
DOIs
StatePublished - Sep 2 2022

Bibliographical note

Funding Information:
Funding/Support: This work was supported by the CDC, the National Vaccine Program Office, the Minnesota Department of Health Newborn Screening Program, and cooperative agreement number 6U19DD001218 from the DRDC.

Funding Information:
Conflict of Interest Disclosures: Dr Schleiss reported receiving grants from the US Centers for Disease Control and Prevention (CDC), the National Institutes of Health, and the University of South Carolina Disability Research and Dissemination Center (DRDC) during the conduct of the study; and receiving personal fees from Moderna, Sanofi, GlaxoSmithKline, and Merck outside the submitted work. Ms Rosendahl and Mr McCann reported receiving grants from the CDC during the conduct of the study. No other disclosures were reported.

Keywords

  • COVID-19/epidemiology
  • Cytomegalovirus
  • Cytomegalovirus Infections/congenital
  • Humans
  • Infant, Newborn
  • Minnesota/epidemiology
  • Pandemics
  • Prevalence

PubMed: MeSH publication types

  • Journal Article
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

Fingerprint

Dive into the research topics of 'Assessment of Congenital Cytomegalovirus Prevalence among Newborns in Minnesota during the COVID-19 Pandemic'. Together they form a unique fingerprint.

Cite this